Allogeneic mesenchymal stem cell infusion for the stabilization offocal segmental glomerulosclerosis

Mirco Belingheri, Lorenza Lazzari, Valentina Parazzi, Elena Groppali, Ettore Biagi, Giuseppe Gaipa, Rosaria Giordano, Maria Pia Rastaldi, Daniela Croci, Andrea Biondi, Paolo Rebulla, Alberto Edefonti, Luciana Ghio

Research output: Contribution to journalArticlepeer-review


Focal segmental glomerulosclerosis (FSGS) is the most frequent acquired renal condition resulting in end stage kidney disease in children. We describe a cell therapy treatment with human allogeneic bone marrow mesenchymal stem cells (MSC) in a 13-year-old patient developing recurrent FSGS after renal transplantation, which was not responding to conventional therapy.This treatment relied on the following measurements:clinical and laboratory evaluation of renal function, proteome array, biopsy, short tandem repeat assay.Before MSC treatment, the patient needed weekly plasmapheresis to achieve proteinuria-to-creatininuria ratio below 5. After three MSC infusions without adverse events, the patient has a stable renal function and the proteinuria target was reached without plasmapheresis. In addition, some circulating inflammatory factors decreased and their levels were still low after one year.This is the first report of an MSC treatment in an FSGS patient. Even though different factors may have contributed to the clinical results, after MSC infusion a stable reduction in the serum level of several inflammatory factors has been registered and the patient does not need anymore plasmapheresis to keep proteinuria under control.In addition, this encouraging single case let us identify some putative efficacy biomarkers that could be of clinical interest in chronic kidney diseases.

Original languageEnglish
Pages (from-to)439-445
Number of pages7
Issue number6
Publication statusPublished - Nov 2013


  • Focal segmental glomerulosclerosis
  • Inflammatory factors
  • Mesenchymal stem cells

ASJC Scopus subject areas

  • Biotechnology
  • Applied Microbiology and Biotechnology
  • Bioengineering
  • Immunology and Microbiology(all)
  • Pharmacology


Dive into the research topics of 'Allogeneic mesenchymal stem cell infusion for the stabilization offocal segmental glomerulosclerosis'. Together they form a unique fingerprint.

Cite this